11/15/24 16:05 | 11/13/24 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | M.d | 26 | 3.74 | 0 | 7 | 143 | 12 | D | | | | | | | | | | | | | | |
11/15/24 16:05 | 11/13/24 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | S.d | -389 | 55.54 | 0 | -7 | -37 | 12 | D | | | | | | | | | | | | | | |
8/9/24 16:05 | 8/7/24 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | M.d | 26 | 3.74 | 0 | 7 | 143 | 12 | D | | | | | | | | | | | | | | |
8/9/24 16:05 | 8/7/24 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | S.d | -322 | 45.94 | 0 | -7 | -37 | 12 | D | | | | | | | | | | | | | | |
5/3/24 16:06 | 5/1/24 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | M.d | 0 | 0.00 | 0 | 3 | 37 | 12 | D | | | | | | | | | | | | | | |
4/28/23 16:04 | 4/27/23 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | M.d | 0 | 0.00 | 0 | 3 | 43 | 9 | D | | | | | | | | | | | | | | |
4/29/22 16:10 | 4/27/22 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | M.d | 0 | 0.00 | 0 | 3 | 74 | 6 | D | | | | | | | | | | | | | | |
9/24/21 19:36 | 9/23/21 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.dm | 997 | 39.88 | 0 | 25 | | 11 | D | | | | | | | | | | | | | | |
9/24/21 19:36 | 9/23/21 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.dm | -4,008 | 160.33 | 0 | -25 | -70 | 11 | D | | | | | | | | | | | | | | |
4/30/21 16:09 | 4/28/21 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | M.d | 0 | 0.00 | 0 | 2 | 100 | 4 | D | | | | | | | | | | | | | | |
1/6/21 19:03 | 1/4/21 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.m | -589 | 123.24 | 0 | -5 | -45 | 6 | D | | | | | | | | | | | | | | |
12/15/20 18:24 | 12/14/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 1,373 | 32.29 | 0 | 43 | | 11 | D | | | | | | | | | | | | | | |
12/15/20 18:24 | 12/14/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -5,535 | 130.14 | 0 | -43 | -79 | 11 | D | | | | | | | | | | | | | | |
12/11/20 18:08 | 12/9/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.dm | 286 | 38.28 | 0 | 7 | 200 | 11 | D | | | | | | | | | | | | | | |
12/11/20 18:08 | 12/9/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.dm | -934 | 125.02 | 0 | -7 | -40 | 11 | D | | | | | | | | | | | | | | |
5/1/20 16:13 | 4/29/20 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | M.d | 0 | 0.00 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
4/10/20 17:29 | 4/8/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.dm | 1,914 | 35.44 | 0 | 54 | | 11 | D | | | | | | | | | | | | | | |
4/10/20 17:29 | 4/8/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.dm | -4,664 | 86.37 | 0 | -54 | -83 | 11 | D | | | | | | | | | | | | | | |
1/3/20 21:41 | 1/2/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -293 | 52.50 | 0 | -6 | -54 | 5 | D | | | | | | | | | | | | | | |
12/17/19 18:39 | 12/13/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -596 | 50.28 | 0 | -12 | -53 | 10 | D | | | | | | | | | | | | | | |
9/10/19 20:22 | 9/10/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -362 | 45.30 | 0 | -8 | -26 | 22 | D | | | | | | | | | | | | | | |
4/11/19 16:58 | 4/9/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -535 | 44.62 | 0 | -12 | -28 | 30 | D | | | | | | | | | | | | | | |
4/4/19 18:07 | 4/2/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -31 | 48.02 | 0 | -1 | -2 | 42 | D | | | | | | | | | | | | | | |
1/4/19 18:34 | 1/2/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -244 | 42.80 | 0 | -6 | -13 | 38 | D | | | | | | | | | | | | | | |
8/31/18 19:00 | 8/30/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 350 | 27.97 | 0 | 13 | 40 | 44 | D | | | | | | | | | | | | | | |
8/31/18 19:00 | 8/30/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -675 | 54.00 | 0 | -13 | -22 | 44 | D | | | | | | | | | | | | | | |
7/3/18 14:32 | 6/29/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 603 | 24.11 | 0 | 25 | 132 | 44 | D | | | | | | | | | | | | | | |
7/3/18 14:32 | 6/29/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -1,200 | 48.00 | 0 | -25 | -36 | 44 | D | | | | | | | | | | | | | | |
4/4/18 16:38 | 4/3/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -154 | 38.45 | 0 | -4 | -8 | 44 | D | | | | | | | | | | | | | | |
1/4/18 19:03 | 1/2/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.dm | -815 | 42.89 | 0 | -19 | -31 | 43 | D | | | | | | | | | | | | | | |
1/4/18 19:03 | 1/3/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 57 | 4.58 | 0 | 13 | 41 | 43 | D | | | | | | | | | | | | | | |
9/14/17 17:02 | 9/12/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -615 | 38.41 | 0 | -16 | -25 | 49 | D | | | | | | | | | | | | | | |
7/7/17 16:55 | 7/5/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 150 | 6.86 | 0 | 22 | 50 | 65 | D | | | | | | | | | | | | | | |
7/7/17 16:55 | 7/5/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -1,101 | 32.00 | 0 | -34 | -35 | 65 | D | | | | | | | | | | | | | | |
1/6/17 17:12 | 1/4/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S | -47 | 27.45 | 12 | -2 | -2 | 71 | D | -29 | -27 | -20 | -25 | -27 | -6 | -1 | 6 | 1 | 0 | -8 | -1 | | |
1/4/17 16:21 | 1/3/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 13 | 10 | 16 | 73 | D | -33 | -43 | -22 | -28 | -33 | -11 | -7 | -1 | -2 | -3 | -14 | -3 | | |
7/7/16 16:04 | 7/7/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 19 | 3.88 | 13 | 5 | 9 | 63 | D | 10 | 16 | -14 | 8 | 0 | -6 | 3 | 1 | 2 | -3 | -2 | 4 | -19 | |
7/6/16 17:45 | 7/1/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 81 | 5.28 | 13 | 15 | 36 | 58 | D | -2 | 8 | -27 | 10 | -4 | -8 | -6 | -6 | -2 | 2 | -1 | 3 | -27 | |
7/6/16 17:45 | 7/1/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -877 | 34.66 | 13 | -25 | -31 | 58 | D | -2 | 8 | -27 | 10 | -4 | -8 | -6 | -6 | -2 | 2 | -1 | 3 | -27 | |
5/25/16 16:29 | 5/23/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 2 | 5.28 | 12 | 0 | 0 | 68 | D | 12 | 3 | -12 | 31 | 9 | 25 | 17 | 5 | -1 | -3 | 1 | -11 | 9 | |
5/25/16 16:29 | 5/23/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -860 | 34.00 | 12 | -25 | -27 | 68 | D | 12 | 3 | -12 | 31 | 9 | 25 | 17 | 5 | -1 | -3 | 1 | -11 | 9 | |
12/23/15 16:54 | 12/22/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 29 | 3.88 | 12 | 8 | 9 | 88 | D | 57 | 22 | 47 | 52 | 27 | 8 | 12 | 7 | 1 | 3 | -27 | -51 | -28 | -44 |
10/9/15 17:04 | 10/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 27 | 3.88 | 10 | 7 | 10 | 80 | D | 5 | -20 | -29 | -19 | -15 | -32 | 0 | -1 | -2 | 1 | 64 | 43 | 26 | 39 |
10/9/15 17:04 | 10/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -171 | 24.38 | 10 | -7 | -8 | 80 | D | 5 | -20 | -29 | -19 | -15 | -32 | 0 | -1 | -2 | 1 | 64 | 43 | 26 | 39 |
9/10/15 16:55 | 9/8/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 25 | 3.88 | 6 | 7 | 19 | 40 | D | | 26 | -24 | -1 | 10 | 1 | 5 | 11 | 4 | 1 | -25 | 31 | -20 | 0 |
9/10/15 16:55 | 9/8/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -196 | 30.16 | 6 | -7 | -14 | 40 | D | | 26 | -24 | -1 | 10 | 1 | 5 | 11 | 4 | 1 | -25 | 31 | -20 | 0 |
8/12/15 17:56 | 8/10/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 25 | 3.88 | 4 | 7 | 19 | 40 | D | | -5 | -25 | -11 | -10 | -12 | -1 | 3 | 13 | 7 | 12 | 35 | -11 | 0 |
8/12/15 17:56 | 8/10/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -185 | 28.53 | 4 | -7 | -14 | 40 | D | | -5 | -25 | -11 | -10 | -12 | -1 | 3 | 13 | 7 | 12 | 35 | -11 | 0 |
7/30/15 17:19 | 7/28/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 19 | 3.88 | 4 | 5 | 14 | 40 | D | | -3 | -29 | -6 | -9 | -6 | -14 | -6 | 2 | 3 | 2 | -3 | 9 | 21 |
7/9/15 16:59 | 7/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 27 | 3.88 | 6 | 7 | 25 | 35 | D | | -1 | -25 | -18 | -17 | -7 | -10 | -4 | 1 | 9 | -7 | -20 | 25 | 14 |
7/9/15 16:59 | 7/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -208 | 29.70 | 6 | -7 | -17 | 35 | D | | -1 | -25 | -18 | -17 | -7 | -10 | -4 | 1 | 9 | -7 | -20 | 25 | 14 |
6/10/15 17:12 | 6/10/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 19 | 3.88 | 5 | 5 | 17 | 35 | D | | -4 | -17 | -24 | 0 | -6 | -8 | -2 | 1 | -2 | -5 | 0 | 37 | 15 |
6/9/15 17:18 | 6/8/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 25 | 3.88 | 5 | 7 | 28 | 30 | D | | 6 | -12 | -20 | 3 | 0 | -2 | 1 | 1 | 0 | -7 | -6 | 36 | 15 |
6/9/15 17:18 | 6/8/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -211 | 32.49 | 5 | -7 | -18 | 30 | D | | 6 | -12 | -20 | 3 | 0 | -2 | 1 | 1 | 0 | -7 | -6 | 36 | 15 |
5/13/15 16:01 | 5/11/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 45 | 3.88 | 6 | 12 | 62 | 30 | D | | -2 | 6 | -15 | -16 | -5 | 12 | 9 | 0 | 3 | 0 | -11 | 21 | -7 |
5/13/15 16:01 | 5/11/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -207 | 31.80 | 6 | -7 | -18 | 30 | D | | -2 | 6 | -15 | -16 | -5 | 12 | 9 | 0 | 3 | 0 | -11 | 21 | -7 |
4/8/15 17:12 | 4/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 27 | 3.88 | 10 | 7 | 39 | 25 | D | | -5 | 10 | -11 | -13 | -17 | -5 | -8 | -3 | -3 | -20 | -16 | -31 | -9 |
4/8/15 17:12 | 4/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -244 | 34.88 | 10 | -7 | -22 | 25 | D | | -5 | 10 | -11 | -13 | -17 | -5 | -8 | -3 | -3 | -20 | -16 | -31 | -9 |
3/10/15 16:08 | 3/9/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 25 | 3.88 | 8 | 7 | 35 | 25 | D | | -20 | 63 | 11 | 0 | 7 | 0 | 0 | 0 | 0 | -14 | -20 | -29 | -32 |
3/10/15 16:08 | 3/9/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -262 | 40.25 | 8 | -7 | -21 | 25 | D | | -20 | 63 | 11 | 0 | 7 | 0 | 0 | 0 | 0 | -14 | -20 | -29 | -32 |
2/11/15 16:02 | 2/9/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 25 | 3.88 | 9 | 7 | 35 | 25 | D | | -17 | 26 | 25 | -3 | -4 | -5 | 0 | -3 | -2 | 8 | -19 | -29 | -36 |
2/11/15 16:02 | 2/9/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -238 | 36.64 | 9 | -7 | -21 | 25 | D | | -17 | 26 | 25 | -3 | -4 | -5 | 0 | -3 | -2 | 8 | -19 | -29 | -36 |
1/13/15 16:27 | 1/12/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 8 | 3.88 | 13 | 2 | 9 | 25 | D | | -13 | 44 | 38 | 6 | 5 | 5 | 3 | 1 | 3 | -3 | -16 | -21 | -13 |
1/13/15 16:27 | 1/12/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -81 | 40.66 | 13 | -2 | -7 | 25 | D | | -13 | 44 | 38 | 6 | 5 | 5 | 3 | 1 | 3 | -3 | -16 | -21 | -13 |
1/9/15 17:47 | 1/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 19 | 3.88 | 15 | 5 | 25 | 25 | D | | 0 | 36 | 36 | 15 | 4 | 6 | 7 | -1 | -1 | -11 | -17 | -27 | -16 |
1/9/15 17:47 | 1/7/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -197 | 39.46 | 15 | -5 | -17 | 25 | D | | 0 | 36 | 36 | 15 | 4 | 6 | 7 | -1 | -1 | -11 | -17 | -27 | -16 |
12/19/14 17:17 | 12/19/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 58 | 3.88 | 16 | 15 | 150 | 25 | D | | 49 | 16 | 67 | 19 | 4 | -7 | 7 | -1 | 4 | 0 | 5 | -17 | 13 |
12/9/14 17:27 | 12/8/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 11 | 10 | New | 10 | D | | 64 | 27 | 73 | 23 | 29 | 11 | 19 | 0 | -13 | -5 | -6 | -28 | -4 |
12/9/14 17:27 | 12/8/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -440 | 44.02 | 11 | -10 | -50 | 10 | D | | 64 | 27 | 73 | 23 | 29 | 11 | 19 | 0 | -13 | -5 | -6 | -28 | -4 |
11/14/14 16:02 | 11/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 8 | 10 | New | 10 | D | | 81 | 10 | 18 | 14 | 3 | 2 | 9 | -1 | 2 | 13 | 14 | -2 | 6 |
11/14/14 16:02 | 11/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -331 | 33.14 | 8 | -10 | -50 | 10 | D | | 81 | 10 | 18 | 14 | 3 | 2 | 9 | -1 | 2 | 13 | 14 | -2 | 6 |
10/27/14 16:38 | 10/27/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 7 | 10 | New | 10 | D | | 47 | 6 | 19 | 34 | 16 | 18 | 18 | 3 | 6 | 4 | 17 | -11 | -25 |
10/9/14 16:59 | 10/7/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 6 | 10 | | 0 | D | | 30 | -20 | 0 | 7 | 23 | 2 | -3 | 2 | 0 | 17 | 40 | 17 | -16 |
10/9/14 16:59 | 10/7/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -293 | 29.25 | 6 | -10 | -100 | 0 | D | | 30 | -20 | 0 | 7 | 23 | 2 | -3 | 2 | 0 | 17 | 40 | 17 | -16 |
9/10/14 20:05 | 9/8/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.dm | 39 | 3.88 | 4 | 10 | | 0 | D | | | -49 | -27 | -15 | -14 | -10 | -5 | 1 | -2 | 19 | 69 | 62 | 22 |
9/10/14 20:05 | 9/8/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.dm | -245 | 24.48 | 4 | -10 | -100 | 0 | D | | | -49 | -27 | -15 | -14 | -10 | -5 | 1 | -2 | 19 | 69 | 62 | 22 |
8/15/14 16:14 | 8/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 5 | 10 | | 0 | D | | | -32 | -5 | -10 | 7 | 1 | 0 | -1 | -12 | -14 | 13 | 27 | 5 |
8/15/14 16:14 | 8/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -298 | 29.78 | 5 | -10 | -100 | 0 | D | | | -32 | -5 | -10 | 7 | 1 | 0 | -1 | -12 | -14 | 13 | 27 | 5 |
7/9/14 17:53 | 7/7/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 12 | 10 | | 0 | D | | | -29 | -20 | -6 | -15 | -17 | -15 | 1 | -10 | -3 | -3 | 27 | -5 |
7/9/14 17:53 | 7/7/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -317 | 31.72 | 12 | -10 | -100 | 0 | D | | | -29 | -20 | -6 | -15 | -17 | -15 | 1 | -10 | -3 | -3 | 27 | -5 |
6/11/14 16:39 | 6/9/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 11 | 10 | | 0 | D | | | 30 | -30 | 0 | 6 | 14 | 11 | 5 | 4 | -7 | -24 | 30 | -4 |
6/11/14 16:39 | 6/9/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -316 | 31.65 | 11 | -10 | -100 | 0 | D | | | 30 | -30 | 0 | 6 | 14 | 11 | 5 | 4 | -7 | -24 | 30 | -4 |
5/21/14 18:51 | 5/19/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | M.d | 39 | 3.88 | 12 | 10 | | 0 | D | | | 61 | -28 | -12 | -8 | 0 | 1 | 6 | 5 | 15 | -3 | 12 | 12 |
5/21/14 18:51 | 5/19/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | O | SVP,CFO, | S.d | -315 | 31.51 | 12 | -10 | -100 | 0 | D | | | 61 | -28 | -12 | -8 | 0 | 1 | 6 | 5 | 15 | -3 | 12 | 12 |
9/5/06 12:23 | 9/1/06 | PRCS | Praecis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | McLaughlin Kevin F | MA | DO | P,CEO | M.d | 32 | 1.33 | 0 | 24 | 116 | 45 | D | | | | | | | | | | | | | | |
2/9/04 16:43 | 2/6/04 | PRCS | Praecis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | McLaughlin Kevin F | MA | O | Exec VP, | M.d | 3 | 0.2700 | 0 | 10 | 11 | 104 | D | | | | | | | | | | | | | | |
12/30/03 17:59 | 12/30/03 | PRCS | Praecis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | McLaughlin Kevin F | MA | O | Senior V | M.d | 1 | 0.2700 | 0 | 2 | 2 | 94 | D | | | | | | | | | | | | | | |
12/3/03 18:29 | 12/2/03 | PRCS | Praecis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | McLaughlin Kevin F | MA | O | SVP,CFO | M.d | 7 | 0.2700 | 0 | 25 | 13 | 219 | D | | | | | | | | | | | | | | |
12/3/03 18:29 | 12/2/03 | PRCS | Praecis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | McLaughlin Kevin F | MA | O | SVP,CFO | S.d | -262 | 7.49 | 0 | -35 | -14 | 219 | D | | | | | | | | | | | | | | |